Breaking News: European Study Reports Halting of Progress of Type 1 Diabetes by Drug Anti-CD3 Antibody

The European study of patients with Type I diabetes found that short-term treatment lowered insulin dependence by 12 percent and increased insulin-making capabilities for at least 18 months.

"The results are very promising. There are not many instances where you can stop an autoimmune disease in its tracks," said Dr. Richard Insel, executive vice president for research of the Juvenile Diabetes Research Foundation.
Full article (235 words) »

Indian’s in High Risk Group for Diabetes

The decision to have the World Congress in India was taken by WHO mainly because every fourth diabetic in the world is an Indian. According to WHO projections, the 30 million to 33 million diabetics in India will go up to 40 million by 2010 and 74 million by 2025.

WHO has issued a warning that India will be the Diabetes capital of the world.

Full article (192 words) »
Protected by Comment Guard Pro